Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type-2 Diabetes Mellitus (T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02588859
What this trial is testing

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,200
Large-scale testing (Phase 3)Looking for participantsNCT07743983
What this trial is testing

BGM0504 in Early T2DM With Obesity

Who this might be right for
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 372
Testing effectiveness (Phase 2)Active Not RecruitingNCT07020377
What this trial is testing

Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).

Who this might be right for
Diabetes MellitusNon Alcholic Fatty Liver Disease
Amira Bisher,PhD 60
Not applicableEnrolling By InvitationNCT07606872
What this trial is testing

Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Insulin ResistanceMetabolic Syndrome
Salah Snouda 150
Not applicableLooking for participantsNCT06588894
What this trial is testing

Investigation of Motor Imagery Ability, Body Awareness and Cognitive Functions in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cognitive FunctionMotor İmagery Ability
Kutahya Health Sciences University 100
Not applicableNot Yet RecruitingNCT07099937
What this trial is testing

Relationship Between Thyroid Dysfunction and Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Thyroid DysfunctionMetabolic Syndrome+1 more
Assiut University 120
Post-approval studies (Phase 4)Looking for participantsNCT05164263
What this trial is testing

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Who this might be right for
Type II Diabetes MellitusEfficacy, SelfSafety Issues
Getz Pharma 2,000
Post-approval studies (Phase 4)Looking for participantsNCT07719894
What this trial is testing

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Atherosclerosis
Seoul National University Bundang Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT01517373
What this trial is testing

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 304
Large-scale testing (Phase 3)Study completedNCT04504370
What this trial is testing

Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 273
Testing effectiveness (Phase 2)Study completedNCT01918865
What this trial is testing

Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObese
Ionis Pharmaceuticals, Inc. 92
Not applicableEnded earlyNCT07014735
What this trial is testing

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Who this might be right for
Diabetes Type 2Hyperglycaemia (Diabetic)QT Interval, Variation in+1 more
Richmond Pharmacology Limited 14
Not applicableNot Yet RecruitingNCT07207694
What this trial is testing

WhatsApp-Based Education Program for Stroke Patients

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Stroke
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital 84
Large-scale testing (Phase 3)Study completedNCT04090580
What this trial is testing

Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone

Who this might be right for
Type 2 Diabetes
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 88
Not applicableStudy completedNCT02707380
What this trial is testing

The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation

Who this might be right for
Type 2 Diabetes (T2DM)Cardiovascular Disease
NYU Langone Health 3
Not applicableStudy completedNCT01548222
What this trial is testing

CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target

Who this might be right for
Type 2 Diabetes
Diabetes Care Center 20
Not applicableStudy completedNCT07332156
What this trial is testing

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Who this might be right for
Type 2 DiabetesCOPD (Chronic Obstructive Pulmonary Disease)Lung Cancer (Diagnosis)
Samsung Medical Center 21,692
Post-approval studies (Phase 4)Study completedNCT02533453
What this trial is testing

A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 110
Large-scale testing (Phase 3)Ended earlyNCT00947557
What this trial is testing

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

Who this might be right for
Diabetes Mellitus, Type II
Forest Laboratories 677
Not applicableStudy completedNCT06961019
What this trial is testing

Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

Who this might be right for
Type2 Diabetes Mellitus
NovoBliss Research Pvt Ltd 14
Next Page